¡@¡@¡@Sample sent on : Decemberr 2, 2004¡@¡@¡@Report deadline¡G December 10, 2004
¡@¡@¡@Total screening unit¡G11¡@¡@¡@¡@¡@¡@Total reports returned¡G11
Sample No. |
A1 |
A2 |
A3 |
B1 | B2 | C1 | C2 | C3 | C4 | C5 | D1 | G6PD activity* |
1 |
76.0 |
2.9 |
7.6 |
2.9 |
¡Ð |
3.1 |
¡Ð |
¡Ð |
4.5 |
6.17 |
2.6 |
6.7 |
2 |
23.7(¡Ï) |
1.1(¡Ï) |
2.5(¡Ï) |
0.7(¡Ï) |
¡Ï |
0.9(¡Ï) |
¡Ï |
¡Ð |
1.5(¡Ï) |
1.87(¡Ï) |
0.9(¡Ï) |
2.0(¡Ï) |
3 |
27.1(¡Ï) |
1.8(¡Ï) |
3.9(¡Ï) |
1.5(¡Ï) |
¡Ð |
1.6 |
¡Ð |
¡Ð |
1.8(¡Ï) |
3.80 |
1.3(¡Ï) |
3.3(¡Ï) |
4 |
45.9 |
2.6 |
6.5 |
2.1 |
¡Ð |
2.5 |
¡Ð |
¡Ð |
2.9 |
4.58 |
3.7 |
5.3 |
5 |
61.6 |
3.2 |
7.5 |
2.8 |
¡Ð |
3.0 |
¡Ð |
¡Ð |
3.1 |
6.39 |
2.6 |
6.7 |
6 |
28.9(¡Ï) |
1.8(¡Ï) |
4.5(¡Ï) |
1.6(¡Ï) |
¡Ð |
1.6 |
¡Ð |
¡Ð |
2.7 |
4.61 |
1.5(¡Ï) |
3.3(¡Ï) |
7 |
54.6 |
2.6 |
6.3 |
2.1 |
¡Ð |
2.3 |
¡Ð |
¡Ð |
3.0 |
6.05 |
2.0(¡Ï) |
5.3 |
8 |
7.9(¡Ï) |
0.2(¡Ï) |
1.0(¡Ï) |
0.07(¡Ï) |
¡Ï |
0.2(¡Ï) |
¡Ï |
¡Ï |
0.8(¡Ï) |
1.35(¡Ï) |
0.2(¡Ï) |
1.2(¡Ï) |
9 |
75.1 |
2.9 |
7.9 |
2.9 |
¡Ð |
3.0 |
¡Ð |
¡Ð |
4.5 |
5.17 |
2.5(¡Ï) |
6.7 |
10 |
34.7(¡Ï) |
1.8(¡Ï) |
4.6(¡Ï) |
1.5(¡Ï) |
¡Ð |
2.1 |
¡Ð |
¡Ð |
2.5 |
3.90 |
1.9(¡Ï) |
3.3(¡Ï) |
¡@¡@¡@* G6PD¡GU/g Hb, determined at Clin. Biochem. Res. Lab, VGH-Taipei
¡@¡@¡@** The positive result assigned by the participants are indicated by red color in the table.
¡@¡@¡@*** The report was not received.
Reagent Kit |
Screening Units |
ASTORIA | A1 |
PE (ND-1000) | A2, B1, C1, D1 |
Roche | C2 |
Sigma Diagnostic 345B | A3 |
Gamma (G6PD-2000) | C4 |
R & D Diagnostics (OSMMR2000-D) | C5 |
Laboratory prepared | B2, C3 |
Preventive Medicine Foundation
Address : P.O. Box 624 Taipei Xinwei, Taiwan, 10699
TEL : +886-2-2703-6080 ; Fax : +886-2-2703-6070
email :
updated : 20 Dec, 2004